Effects of COVID-19 prevention procedures on other common infections: a systematic review

Dadras, Omid; Mehraeen, Esmaeil; Karimi, Amirali; MohsseniPour, Mehrzad; Barzegary, Alireza; Vahedi, Farzin; Pashaei, Zahra; Mirzapour, Pegah; Fakhfouri, Amirata; Zargari, Ghazal; Saeidi, Solmaz; Mojdeganlou, Hengameh; Badri, Hajar; Qaderi, Kowsar; Behnezhad, Farzane; Mehraeen, Esmaeil

doi:10.1186/s40001-021-00539-1

Cited by 78 publications

(58 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The spread of other infectious diseases cannot be ignored in the context of COVID-19. Studies have shown that these NPIs for COVID-19 may also reduce the incidence of respiratory infectious diseases such as influenza (7), as well as the number of other infectious diseases reported. Similar reports have been reported in the United States (8) and Germany (9).…”

Section: Introductionmentioning

confidence: 99%

Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19

Chen

Wang

Huang

et al. 2021

Front. Public Health

View full text Add to dashboard Cite

Aim: The aim of this study was to analyze the changes in incidence of notifiable infectious diseases in China under the prevention and control measures of COVID-19.Methods: Using descriptive epidemiological methods, data were collected from the official website of the Health Commission of the People's Republic of China, and the prevalence characteristics of notifiable infectious diseases in the country in 2020 were analyzed and compared with the historical data in 2019. Monthly reporting data on influenza and tuberculosis from 2015 to 2019 were also collected.Results: Except for COVID-19, the total number of notifiable infectious diseases cases in 2020 was 6,366,176, a decrease of 41.38% year-on-year compared with 2019. Category B and C notifiable infectious diseases decreased by 14.84 and 54.98% year-on-year, respectively (P < 0.01). The top three incidence rates were influenza (87.63 cases/100,000), hepatitis B (81.36 cases/100,000) and other infectious diarrhea (76.33 cases/100,000). Three types of diseases with the largest decline were influenza (−2,280,502 cases), hand-foot-mouth disease (−1,174,588 cases), and other infectious diarrhea diseases (−275,746 cases). Compared with 2019, respiratory infectious diseases were reported to be in the largest decline in 2020, followed by intestinal infectious diseases, blood-borne and sexually transmitted diseases, natural foci, and insect-borne infectious diseases. The monthly reported incidences of influenza and tuberculosis in 2020 were lower than the average of the previous 5 years.Conclusion: In 2020, the incidence of most notifiable infectious diseases in China showed a downward trend, non-pharmaceutical interventions (NPIs)such as the wearing of masks, frequent hand-washing, more ventilation, less gathering, etc, played an positive role in the prevention and control of respiratory and intestinal infectious diseases. The various public health intervention strategies and measures adopted by China to contain COVID-19 can provide a reference for the prevention and control of infectious diseases in other countries.

show abstract

Section: Introductionmentioning

confidence: 99%

Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19

Chen

Wang

Huang

et al. 2021

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…COVID-19 is an acute respiratory infection caused by the SARS-CoV-2; it emerged as a novel human pathogen in China at the end of 2019 continues to be a pandemic worldwide [ 1 – 4 ]. The most common manifestations are pneumonia, high fever, myalgia, dry cough, and chest pain [ 5 – 9 ]. The death rate due to COVID-19 varies from 1% to more than 7%, and respiratory failure is the main cause [ 10 , 11 ].…”

Section: Introductionmentioning

confidence: 99%

The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review

et al. 2021

Self Cite

View full text Add to dashboard Cite

Background Oxygenation serves as a cornerstone in the treatment of COVID-19, and several methods have been extensively studied so far. Herein, we aimed to systematically review the studies discussing hyperbaric oxygen therapy (HBOT) to examine its reported efficacy and adverse events in patients with COVID-19. Methods We systematically searched and retrieved the relevant articles using keywords on the online databases, including PubMed, Scopus, Embase, Web of Science, and Cochrane databases up to April 11th, 2021. The retrieved records underwent a two-step title/abstract and full-text screening process, and the eligible papers were identified. National Institutes of health (NIH) quality assessment tool was used for this study. This study was registered in the International Prospective Register of Systematic Reviews (PROSPERO) with ID CRD42021269821. Results Eight articles from three countries were included. All the included studies had good and fair quality scores, with no poor studies included in this systematic review (Good: n = 5, Fair: n = 3). Studies were divided into clinical trials and case reports/series. Most of the studies used HBOT less than 1.5–2 absolute atmospheres (ATA) for 90 min sessions and thereafter sessions were decreased to 60 min. Trials demonstrated most of the patients recovered after receiving HBOT, and blood oxygen saturation increased after several sessions of HBOT. Conclusion Overall, HBOT seems to be a safe and effective oxygenation method in patients with COVID-19. However, there is limited knowledge and evidence regarding the effects and mechanism of HBOT in COVID-19 treatment, and further evaluations require extensive well-designed studies.

show abstract

“…As the spreading of the COVID-19 virus is increasing globally, various guidelines are being issued by the World Health Organization (WHO) for disease control and prevention [140,141]. It is a personal feeling that virus prevention can be done by taking some measures and incorporating them into our daily life.…”

Section: Preventive Procedures From Virusmentioning

confidence: 99%

Nanotechnology Integration for SARS-CoV-2 Diagnosis and Treatment: An Approach to Preventing Pandemic

Asdaq¹,

Ikbal

Sahu

et al. 2021

Nanomaterials

View full text Add to dashboard Cite

The SARS-CoV-2 outbreak is the COVID-19 disease, which has caused massive health devastation, prompting the World Health Organization to declare a worldwide health emergency. The corona virus infected millions of people worldwide, and many died as a result of a lack of particular medications. The current emergency necessitates extensive therapy in order to stop the spread of the coronavirus. There are various vaccinations available, but no validated COVID-19 treatments. Since its outbreak, many therapeutics have been tested, including the use of repurposed medications, nucleoside inhibitors, protease inhibitors, broad spectrum antivirals, convalescence plasma therapies, immune-modulators, and monoclonal antibodies. However, these approaches have not yielded any outcomes and are mostly used to alleviate symptoms associated with potentially fatal adverse drug reactions. Nanoparticles, on the other hand, may prove to be an effective treatment for COVID-19. They can be designed to boost the efficacy of currently available antiviral medications or to trigger a rapid immune response against COVID-19. In the last decade, there has been significant progress in nanotechnology. This review focuses on the virus’s basic structure, pathogenesis, and current treatment options for COVID-19. This study addresses nanotechnology and its applications in diagnosis, prevention, treatment, and targeted vaccine delivery, laying the groundwork for a successful pandemic fight.

show abstract

Effects of COVID-19 prevention procedures on other common infections: a systematic review

Cited by 78 publications

References 42 publications

Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19

Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19

The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review

Nanotechnology Integration for SARS-CoV-2 Diagnosis and Treatment: An Approach to Preventing Pandemic

Contact Info

Product

Resources

About